Team offers an open solution to improving research reproducibility

byMcGill UniversityLab work. Credit: The Neuro (Montreal Neurological Institute-Hospital)Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McG

Updated on: January 19,2025 0

Team offers an open solution to improving research reproducibility

byMcGill UniversityLab work. Credit: The Neuro (Montreal Neurological Institute-Hospital)Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McG

Updated on:January 19,2025 0

GLP-1 Zepbound is approved as first drug for sleep apnea

by India EdwardsThe U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.In a n

Updated on: January 18,2025 0

GLP-1 Zepbound is approved as first drug for sleep apnea

by India EdwardsThe U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound.In a n

Updated on:January 18,2025 0

FDA expands approval of Vtama to include atopic dermatitis

FDA expands approval of Vtama to include atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the

Updated on: January 18,2025 0

FDA expands approval of Vtama to include atopic dermatitis

FDA expands approval of Vtama to include atopic dermatitisby Lori SolomonThe U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the

Updated on:January 18,2025 0

Upadacitinib found to improve ulcerative colitis outcomes at 12 months

by Elana GotkineFor patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a studypublished&nbs

Updated on: January 17,2025 0

Upadacitinib found to improve ulcerative colitis outcomes at 12 months

by Elana GotkineFor patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a studypublished&nbs

Updated on:January 17,2025 0

Study explores whether CBD can reduce scan-related anxiety in patients with advanced breast cancer

byBrigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainAnxiety is extremely common among adults receiving cancer care, with as many as one out of every four patients meeting the clinical

Updated on: January 17,2025 0

Study explores whether CBD can reduce scan-related anxiety in patients with advanced breast cancer

byBrigham and Women’s HospitalCredit: Pixabay/CC0 Public DomainAnxiety is extremely common among adults receiving cancer care, with as many as one out of every four patients meeting the clinical

Updated on:January 17,2025 0